How do you make the case for US foreign aid to an Administration that has proposed slashing it? That was the task for Mark Suzman, Chief Strategy Officer and president of Global Policy and Advocacy for the Bill & Melinda Gates Foundation, when he recently accompanied Bill Gates to meetings at the White House. In this week's CGD podcast, Suzman gives us two very different versions of the fight against global poverty and disease—the perception and the reality. At an event called Financing the Future, he joined CGD experts Masood Ahmed, Amanda Glassman, and Antoinette Sayeh to discuss ways the development community can better convey their results.
CGD Policy Blogs
Here in the US, the Congress is wrestling with proposals to replace the Obama-era health reform. One strategy on the table is to modify the benefits that are legally required to be included in health insurance policies; in her confirmation hearing, incoming CMS Administrator Seema Verma suggested that maternity care could be dropped from the list of essential benefits.
Cost-effectiveness analysis (CEA) can help countries attain and sustain universal health coverage (UHC), as long as it is context-specific and considered within deliberative processes at the country level. Institutionalising robust deliberative processes requires significant time and resources, however, and countries often begin by demanding evidence (including local CEA evidence as well as evidence about local values), whilst striving to strengthen the governance structures and technical capacities with which to generate, consider and act on such evidence. In low- and middle-income countries (LMICs), such capacities could be developed initially around a small technical unit in the health ministry or health insurer. The role of networks, development partners, and global norm setting organisations is crucial in supporting the necessary capacities.
What Do the Trump Administration's Budget Cuts Mean—and What Do They Mask? – Podcast with Scott Morris and Amanda Glassman
What do the cuts mean for the people most affected and for America’s role as a global development leader? That’s the subject of this edition of the CGD Podcast.
This week, the Board of the Global Fund to Fight AIDS, Tuberculosis, and Malaria was set to name the organization’s new executive director. Instead, after the shortlist of candidates appeared in the New York Times, some in the global health community anonymously expressed concerns about the selection process and its results—and the Board abruptly announced it would restart the process from scratch. As the executive director search reboots, I am looking for candidates that have clarity, concrete plans, and capacity to make progress in three areas—the big 3—that are essential to the Fund’s survival: results, efficiency, and money.